NCT06115642
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06115642 |
| Title | A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors |
| Recruitment | Enrolling by invitation |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Shanghai Henlius Biotech |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
CKB BOOST